Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Taiyen Biotech Co's 3-Year RORE % for the quarter that ended in Dec. 2025 was 36.57%.
The industry rank for Taiyen Biotech Co's 3-Year RORE % or its related term are showing as below:
TPE:1737's 3-Year RORE % is ranked better than 74.02% of 1828
companies
in the Consumer Packaged Goods industry
Industry Median: 6.025
vs TPE:1737: 36.57
Taiyen Biotech Co (TPE:1737) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Taiyen Biotech Co 3-Year RORE % Related Terms
Taiyen Biotech Co 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1737 vs PG, CL, KVUE: 3-Year RORE % Comparison
For the Household & Personal Products subindustry, Taiyen Biotech Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co 3-Year RORE % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Taiyen Biotech Co (TPE:1737) has a 3-Year RORE % of 36.57 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Taiyen Biotech Co and its competitors. According to the industry distribution chart, Taiyen Biotech Co ranks #475 out of 1828 companies in the Consumer Packaged Goods industry, placing it in the top 26%.
Is Taiyen Biotech Co's 3-Year RORE % too high?
Taiyen Biotech Co's current 3-Year RORE % is 36.57. The Consumer Packaged Goods industry median 3-Year RORE % is 6.03. Taiyen Biotech Co's value of 36.57 is 507% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #475 out of 1828 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Taiyen Biotech Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's 3-Year RORE % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #475 out of 1828 companies for 3-Year RORE %. This puts Taiyen Biotech Co in the upper half of its industry. The industry median 3-Year RORE % is 6.03. Taiyen Biotech Co's value of 36.57 is 507% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Consumer Packaged Goods company?
The median 3-Year RORE % among Consumer Packaged Goods companies is 6.03, based on 1,828 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current 3-Year RORE % of 36.57 is 507% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median 3-Year RORE % is 6.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current 3-Year RORE % is 36.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.05, compared to a current price of NT$32.00 — trading 0.2% below its estimated fair value. The current 3-Year RORE % is 36.57 and 507% above the Consumer Packaged Goods industry median of 6.03. Taiyen Biotech Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current 3-Year RORE % is 36.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$32.00 is trading 0.2% below its estimated GF Value™ of NT$32.05.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
3-Year RORE %: 36.57
GF Value™: NT$32.05 vs. price of NT$32.00 (0.2% below fair value)
Industry Position: 507% above the Consumer Packaged Goods median (#475 of 1828)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
82GF Score
Get the complete analysis for TPE:1737
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
